This website uses cookies to improve functionality and performance. With a click on the OK button you are giving implied consent to the use of cookies on this website.
More information
EnglishDeutsch
de
EnglishDeutsch
de
Login Environment Pharma

Next Generation Sequencing – SYNLAB develops and performs customized gene analyzes

SYNLAB  Pharma develops and performs customised gene analyses.

  • Ultra high-throughput DNA analysis using semiconductor sequencing technology.
  • Characterisation of up to 16 genes of cytochrome P450 in parallel, based on customer requirements.
  • The sequencing of all exons of cytochrome P450 is available.
  • The set of genes analysed is individually selectable according to customer requirements.
  • Characterisation of more than 400 of the most relevant polymorphisms of CYP alleles.
  • Detection of duplication and deletion (Copy Number Variations).
  • Specific analysis of drug intolerance or modified drug reactions.
Contact us



News & Events

View All
Fellbach wird neuer Laborstandort
Nach zweijähriger Planungs- und Umbauphase entstand in Fellbach das neue Labor der SYNLAB Analytics & Services Germany GmbH.
Aug 10, 2018 Continue
Determination of the Impurity N-Nitroso dimethyl amine (NDMA) in Drug Substances with GC-MS

Due to contamination of a drug substance with the potential mutagenic substance N-Nitroso dimethyl amine (NDMA) a massive recall campaign was initiated for the related drug products. SYNLAB Pharma offers a GC-MS test for testing the absence of NDMA in drug substances and drug products.

Please contact our experts.

Jul 13, 2018 | Pharma Continue
New Services in Regulatory Compliance for Biologics

With immediate effect, SYNLAB Pharma provides a broad support in the field of Regulatory Compliance of Biologics development. With this new services we support specifically start-ups, small to medium sized biotech companies, which require professional consultancy and project execution in regulatory project design.

For further questions, please contact:

pharma@synlab.com

Jun 18, 2018 | Pharma Continue
View All